Evidence map›Paper›PMID 25279986›Full record

ArticleAmerican journal of human genetics2014

Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.

Christine F Skibola, Sonja I Berndt, Joseph Vijai, Lucia Conde, Zhaoming Wang, Meredith Yeager, Paul I W de Bakker, Brenda M Birmann, Claire M Vajdic, Jia-Nee Foo and 102 more

Open access · bronzeAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of human genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 4 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 4 syntheses or guidelines pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

112 authors at 20 institutions in 17 countries.

Christine F SkibolaDepartment of Epidemiology, School of Public Health and Comprehensive Cancer Center, Birmingham, AL 35233, USA; Division of Environmental Health Sciences, University of California Berkeley School of Public Health, Berkeley, CA 94720, USA. Electronic address: cskibola@uab.edu.
Sonja I BerndtDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Joseph VijaiDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Lucia CondeDepartment of Epidemiology, School of Public Health and Comprehensive Cancer Center, Birmingham, AL 35233, USA; Division of Environmental Health Sciences, University of California Berkeley School of Public Health, Berkeley, CA 94720, USA.
Zhaoming WangCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, MD 20877, USA.
Meredith YeagerCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, MD 20877, USA.
Paul I W de BakkerDepartment of Medical Genetics and of Epidemiology, University Medical Center Utrecht, Utrecht 3584 CG, the Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht 3584 CX, the Netherlands.
Brenda M BirmannChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Claire M VajdicPrince of Wales Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
Jia-Nee FooHuman Genetics, Genome Institute of Singapore, Singapore 138672, Singapore.
Paige M BracciDepartment of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA 94118, USA.
Roel C H VermeulenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht 3584 CX, the Netherlands; Institute for Risk Assessment Sciences, Utrecht University, Utrecht 3508 TD, the Netherlands.
Susan L SlagerDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
Silvia de SanjoseUnit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Catala d'Oncologia, IDIBELL, Barcelona 8907, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona 8036, Spain.
Sophia S WangDepartment of Cancer Etiology, City of Hope Beckman Research Institute, Duarte, CA 91030, USA.
Martha S LinetDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Gilles SallesDepartment of Hematology, Hospices Civils de Lyon, Pierre benite Cedex 69495, France; Department of Hematology, Université Lyon-1, Pierre benite Cedex 69495, France; Laboratoire de Biologie Moléculaire de la Cellule UMR 5239, Centre National de la Recherche Scientifique, Pierre benite Cedex 69495, France.
Qing LanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Gianluca SeveriHuman Genetics Foundation, Turin 10126, Italy; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC 3053, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Carlton, VIC 3010, Australia.
Henrik HjalgrimDepartment of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen 2300, Denmark.
Tracy LightfootDepartment of Health Sciences, University of York, York YO10 5DD, UK.
Mads MelbyeDepartment of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen 2300, Denmark; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Jian GuDepartment of Epidemiology, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Hervé GhesquièresLaboratoire de Biologie Moléculaire de la Cellule UMR 5239, Centre National de la Recherche Scientifique, Pierre benite Cedex 69495, France; Department of Hematology, Centre Léon Bérard, Lyon 69008, France.
Brian K LinkDepartment of Internal Medicine, Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USA.
Lindsay M MortonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Elizabeth A HollyDepartment of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA 94118, USA.
Alex SmithDepartment of Health Sciences, University of York, York YO10 5DD, UK.
Lesley F TinkerDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98117, USA.
Lauren R TerasEpidemiology Research Program, American Cancer Society, Atlanta, GA 30303, USA.
Anne KrickerSydney School of Public Health, The University of Sydney, Sydney, NSW 2006, Australia.
Nikolaus BeckerDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg 69120, Germany.
Mark P PurdueDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
John J SpinelliCancer Control Research, BC Cancer Agency, Vancouver, BC V5Z 1L3, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Yawei ZhangDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT 06520, USA.
Graham G GilesCancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC 3053, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Carlton, VIC 3010, Australia.
Paolo VineisHuman Genetics Foundation, Turin 10126, Italy; MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London W2 1PG, UK.
Alain MonnereauEnvironmental Epidemiology of Cancer Group, Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Villejuif Cedex 94807, France; UMRS 1018, Université Paris Sud, Villejuif Cedex 94807, France; Registre des hémopathies malignes de la Gironde, Institut Bergonié, Bordeaux Cedex 33076, France.
Kimberly A BertrandChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA.
Demetrius AlbanesDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Anne Zeleniuch-JacquotteDepartment of Population Health, New York University School of Medicine, New York, NY 10016, USA; Cancer Institute, New York University School of Medicine, New York, NY 10016, USA.
Attilio GabbasDepartment of Public Health, Clinical and Molecular Medicine, University of Cagliari, Monserrato, Cagliari 09042, Italy.
Charles C ChungDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Laurie BurdettCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, MD 20877, USA.
Amy HutchinsonCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, MD 20877, USA.
Charles LawrenceHealth Studies Sector, Westat, Rockville, MD 20850, USA.
Rebecca MontalvanHealth Studies Sector, Westat, Rockville, MD 20850, USA.
Liming LiangDepartment of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA; Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA.
Jinyan HuangDepartment of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA.
Baoshan MaDepartment of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA; College of Information Science and Technology, Dalian Maritime University, Dalian, Liaoning Province 116026, China.
Jianjun LiuHuman Genetics, Genome Institute of Singapore, Singapore 138672, Singapore.
Hans-Olov AdamiDepartment of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.
Bengt GlimeliusDepartment of Oncology and Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm 17176, Sweden; Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala 75105, Sweden.
Yuanqing YeDepartment of Epidemiology, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Grzegorz S NowakowskiDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
Ahmet DoganDepartments of Laboratory Medicine and Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Carrie A ThompsonDepartment of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Thomas M HabermannDepartment of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Anne J NovakDepartment of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Mark LiebowDepartment of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Thomas E WitzigDepartment of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
George J WeinerDepartment of Internal Medicine, Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USA.
Maryjean SchenkDepartment of Family Medicine and Public Health Sciences, Wayne State University, Detroit, MI 48201, USA.
Patricia HartgeDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Anneclaire J De RoosDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98117, USA; Department of Environmental and Occupational Health, Drexel University School of Public Health, Philadelphia, PA 19104, USA.
Wendy CozenDepartment of Preventive Medicine, USC Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA; Norris Comprehensive Cancer Center, USC Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Degui ZhiDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Nicholas K AkersDivision of Environmental Health Sciences, University of California Berkeley School of Public Health, Berkeley, CA 94720, USA.
Jacques RibyDepartment of Epidemiology, School of Public Health and Comprehensive Cancer Center, Birmingham, AL 35233, USA; Division of Environmental Health Sciences, University of California Berkeley School of Public Health, Berkeley, CA 94720, USA.
Martyn T SmithDivision of Environmental Health Sciences, University of California Berkeley School of Public Health, Berkeley, CA 94720, USA.
Mortimer LacherDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Danylo J VillanoDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Ann MariaDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Eve RomanDepartment of Health Sciences, University of York, York YO10 5DD, UK.
Eleanor KaneDepartment of Health Sciences, University of York, York YO10 5DD, UK.
Rebecca D JacksonDivision of Endocrinology, Diabetes and Metabolism, The Ohio State University, Columbus, OH 43210, USA.
Kari E NorthDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Carolina Center for Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
W Ryan DiverEpidemiology Research Program, American Cancer Society, Atlanta, GA 30303, USA.
Jenny TurnerDepartment of Anatomical Pathology, Australian School of Advanced Medicine, Macquarie University, Sydney, NSW 2109, Australia; Department of Histopathology, Douglass Hanly Moir Pathology, Macquarie Park, NSW 2113, Australia.
Bruce K ArmstrongSydney School of Public Health, The University of Sydney, Sydney, NSW 2006, Australia.
Yolanda BenaventeUnit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Catala d'Oncologia, IDIBELL, Barcelona 8907, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona 8036, Spain.
Paolo BoffettaThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Paul BrennanGroup of Genetic Epidemiology, Section of Genetics, International Agency for Research on Cancer, Lyon 69372, France.
Lenka ForetovaDepartment of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and MF MU, Brno 656 53, Czech Republic.
Marc MaynadieEA 4184, Registre des Hémopathies Malignes de Côte d'Or, University of Burgundy and Dijon University Hospital, Dijon 21070, France.
Anthony StainesSchool of Nursing and Human Sciences, Dublin City University, Dublin 9, Ireland.
James McKayGenetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer, Lyon 69372, France.
Angela R Brooks-WilsonGenome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z 1L3, Canada; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
Tongzhang ZhengDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT 06520, USA.
Theodore R HolfordDepartment of Biostatistics, Yale School of Public Health, New Haven, CT 06520, USA.
Saioa ChamosaHealth Department, BioDonostia Research Institute, Basque Region 20014, Spain.
Rudolph KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg 69120, Germany.
Rachel S KellyMRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London W2 1PG, UK; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA.
Bodil OhlssonDepartment of Clinical Sciences, Division of Internal Medicine, Skåne University Hospital, Lund University, Malmö 205 02, Sweden.
Ruth C TravisCancer Epidemiology Unit, University of Oxford, Oxford OX3 7LF, UK.
Elisabete WeiderpassDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, Breivika 9037, Norway; Cancer Registry of Norway, Oslo 0304, Norway; Department of Genetic Epidemiology, Folkhalsan Research Center, Helsinki 00250, Finland.
Jacqueline ClavelEnvironmental Epidemiology of Cancer Group, Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Villejuif Cedex 94807, France; UMRS 1018, Université Paris Sud, Villejuif Cedex 94807, France.
Edward GiovannucciChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA; Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA.
Peter KraftDepartment of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA; Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA.
Jarmo VirtamoDepartment of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki 00271, Finland.
Patrizio MazzaDepartment of Hematology, Ospedale Nord, Taranto 74100, Italy.
Pierluigi CoccoDepartment of Public Health, Clinical and Molecular Medicine, University of Cagliari, Monserrato, Cagliari 09042, Italy.
Maria Grazia EnnasDepartment of Biomedical Science, University of Cagliari, Monserrato, Cagliari 09042, Italy.
Brian C H ChiuDepartment of Health Studies, University of Chicago, Chicago, IL 60637, USA.
Joseph F FraumeniDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Alexandra NietersCenter for Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg, Baden-Württemberg 79108, Germany.
Kenneth OffitDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Xifeng WuDepartment of Epidemiology, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
James R CerhanDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
Karin E SmedbyDepartment of Medicine Solna, Karolinska Institutet, Stockholm 17176, Sweden.
Stephen J ChanockDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Nathaniel RothmanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
National Cancer Institute · USDivision of Cancer Epidemiology and GeneticsHarvard University · USMemorial Sloan Kettering Cancer Center · USMayo Clinic in Arizona · USUniversity of York · GBBerkeley Public Health Division · USMayo Clinic in Florida · USThe University of Texas MD Anderson Cancer Center · USUniversity of Cagliari · ITYale University · USAmerican Cancer Society · USBC Cancer Agency · CABrigham and Women's Hospital · USCentre international de recherche sur le cancer · FRFred Hutch Cancer Center · USGenome Institute of Singapore · SGHeidelberg University · DEKarolinska Institutet · SEThe University of Sydney · AU

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI STANLEY R. HAMILTON · 1985 to 2026
$86.3M
Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI DAVID L RIMM · 1985 to 2026
$85.0M
Training CoreP42ES004705 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI MORELLO-FROSCH, RACHEL ADELE · 1987 to 2025
$74.6M
Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
The Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI WEINER, GEORGE J. · 2002 to 2021
$45.7M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Multidisciplinary Studies of LymphomaZIACP010170 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI MORTON, LINDSAY · 2009 to 2025
$10.7M
Cancer Research UK 16491Intramural NIH HHSNCATS NIH HHS UL1 TR000142NCATS NIH HHS UL1 TR000430NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA015083NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA033572NCI NIH HHS R01 CA149445NCI NIH HHS R01 CA154643NIEHS NIH HHS P30 ES010126NIEHS NIH HHS P42 ES004705World Health Organization 001
6 · The paper itself

Abstract

Genome-wide association studies (GWASs) of follicular lymphoma (FL) have previously identified human leukocyte antigen (HLA) gene variants. To identify additional FL susceptibility loci, we conducted a large-scale two-stage GWAS in 4,523 case subjects and 13,344 control subjects of European ancestry. Five non-HLA loci were associated with FL risk: 11q23.3 (rs4938573, p = 5.79 × 10(-20)) near CXCR5; 11q24.3 (rs4937362, p = 6.76 × 10(-11)) near ETS1; 3q28 (rs6444305, p = 1.10 × 10(-10)) in LPP; 18q21.33 (rs17749561, p = 8.28 × 10(-10)) near BCL2; and 8q24.21 (rs13254990, p = 1.06 × 10(-8)) near PVT1. In an analysis of the HLA region, we identified four linked HLA-DRβ1 multiallelic amino acids at positions 11, 13, 28, and 30 that were associated with FL risk (pomnibus = 4.20 × 10(-67) to 2.67 × 10(-70)). Additional independent signals included rs17203612 in HLA class II (odds ratio [OR(per-allele)] = 1.44; p = 4.59 × 10(-16)) and rs3130437 in HLA class I (OR(per-allele) = 1.23; p = 8.23 × 10(-9)). Our findings further expand the number of loci associated with FL and provide evidence that multiple common variants outside the HLA region make a significant contribution to FL risk.

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyAllelesBiomarkers, TumorCase-Control StudiesChromosomes, HumanHaplotypesHLA AntigensHumansLymphoma, FollicularPolymorphism, Single NucleotideBiomarkers, TumorHLA Antigens

Identifiers

PMID25279986
PMCPMC4185120
OpenAlexW2088182134

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.